These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 8676222)

  • 61. Thrombosis in patients with acute promyelocytic leukemia treated with and without all-trans retinoic acid.
    Escudier SM; Kantarjian HM; Estey EH
    Leuk Lymphoma; 1996 Feb; 20(5-6):435-9. PubMed ID: 8833399
    [TBL] [Abstract][Full Text] [Related]  

  • 62. All-trans-retinoic acid and arsenic trioxide as initial therapy for acute promyelocytic leukemia.
    Quezada G; Kopp L; Estey E; Wells RJ
    Pediatr Blood Cancer; 2008 Jul; 51(1):133-5. PubMed ID: 18293388
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Tamibarotene in patients with acute promyelocytic leukaemia relapsing after treatment with all-trans retinoic acid and arsenic trioxide.
    Sanford D; Lo-Coco F; Sanz MA; Di Bona E; Coutre S; Altman JK; Wetzler M; Allen SL; Ravandi F; Kantarjian H; Cortes JE
    Br J Haematol; 2015 Nov; 171(4):471-7. PubMed ID: 26205361
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Scrotal ulceration induced by all-trans retinoic acid in a patient with acute promyelocytic leukemia.
    Mourad YA; Jabr F; Salem Z
    Int J Dermatol; 2005 Jan; 44(1):68-9. PubMed ID: 15663666
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Successful treatment of acute promyelocytic leukemia using all-trans retinoic acid and erythropoietin in a Jehovah's Witness boy.
    Menéndez A; Svarch E; Martínez G; Hernández P
    Ann Hematol; 1998 Jan; 76(1):43-4. PubMed ID: 9486924
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Multi-institutional study of all-trans-retinoic acid as a differentiation therapy of refractory acute promyelocytic leukemia. Leukaemia Study Group of the Ministry of Health and Welfare.
    Ohno R; Yoshida H; Fukutani H; Naoe T; Ohshima T; Kyo T; Endoh N; Fujimoto T; Kobayashi T; Hiraoka A
    Leukemia; 1993 Nov; 7(11):1722-7. PubMed ID: 8231241
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A unique case of acute promyelocytic leukemia showing monocytic differentiation after ATRA (all-trans retinoic acid) therapy.
    Naeem M; Harrison K; Barton K; Nand S; Alkan S
    Eur J Haematol; 2006 Feb; 76(2):164-6. PubMed ID: 16405439
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Treatment with all-trans retinoic acid in acute promyelocytic leukemia reduces early deaths in children.
    Mann G; Reinhardt D; Ritter J; Hermann J; Schmitt K; Gadner H; Creutzig U
    Ann Hematol; 2001 Jul; 80(7):417-22. PubMed ID: 11529468
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparison of anthracycline-based combination chemotherapy with or without all-trans retinoic acid in acute promyelocytic leukemia.
    Raza S; Ullah K; Ahmed P; Khan B
    J Coll Physicians Surg Pak; 2008 Sep; 18(9):546-50. PubMed ID: 18803891
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Intravascular haemolysis complicating treatment of acute promyelocytic leukaemia with all-trans retinoic acid (ATRA).
    Hogan CJ; Wiley JS; Billington T
    Aust N Z J Med; 1997 Aug; 27(4):450-1. PubMed ID: 9448894
    [No Abstract]   [Full Text] [Related]  

  • 71. The role of maintenance therapy in acute promyelocytic leukemia in the first complete remission.
    Muchtar E; Vidal L; Ram R; Gafter-Gvili A; Shpilberg O; Raanani P
    Cochrane Database Syst Rev; 2013 Mar; (3):CD009594. PubMed ID: 23543579
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Acute promyelocytic leukemia with isochromosome 17q and cryptic PML-RARA successfully treated with all-trans retinoic acid and arsenic trioxide.
    Shepshelovich D; Oniashvili N; Parnes D; Klein A; Muchtar E; Yeshaya J; Aviram A; Rabizadeh E; Raanani P
    Cancer Genet; 2015 Nov; 208(11):575-9. PubMed ID: 26471811
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Scrotal ulcer occurring in patients with acute promyelocytic leukemia during treatment with all-trans retinoic acid.
    Mori A; Tamura S; Katsuno T; Nishimura Y; Itoh T; Saheki K; Takatsuka H; Wada H; Fujimori Y; Okamoto T; Takemoto Y; Kakishita E
    Oncol Rep; 1999; 6(1):55-8. PubMed ID: 9864401
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Thrombotic complications in acute promyelocytic leukemia during all-trans-retinoic acid therapy.
    Pogliani EM; Rossini F; Casaroli I; Maffe P; Corneo G
    Acta Haematol; 1997; 97(4):228-30. PubMed ID: 9158667
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Differential uptake of all-trans retinoic acid by acute promyelocytic leukemic cells: evidence for its role in retinoic acid efficacy.
    Agadir A; Cornic M; Lefebvre P; Gourmel B; Balitrand N; Degos L; Chomienne C
    Leukemia; 1995 Jan; 9(1):139-45. PubMed ID: 7845008
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Long-term follow-up of hemostatic molecular markers during remission induction therapy with all-trans retinoic acid for acute promyelocytic leukemia. Keio Hematology-Oncology Cooperative Study Group (KHOCS).
    Watanabe R; Murata M; Takayama N; Tokuhira M; Kizaki M; Okamoto S; Kawai Y; Watanabe K; Murakami H; Kikuchi M; Nakamura S; Ikeda Y
    Thromb Haemost; 1997 Apr; 77(4):641-5. PubMed ID: 9134635
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The success and the challenge of all-trans retinoic acid in the treatment of cancer.
    Ni X; Hu G; Cai X
    Crit Rev Food Sci Nutr; 2019; 59(sup1):S71-S80. PubMed ID: 30277803
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Prediction of growth sensitivity of acute promyelocytic leukemia cells to granulocyte colony-stimulating factor using 7AAD/PY during administration of all-trans retinoic acid.
    Toba K; Koike T; Wang Y; Nagai K; Takahashi H; Hashimoto S; Uesugi Y; Aizawa Y
    Int J Hematol; 1997 Aug; 66(2):203-12. PubMed ID: 9277051
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Overview of all-trans-retinoic acid (ATRA) and its analogues: Structures, activities, and mechanisms in acute promyelocytic leukaemia.
    Liang C; Qiao G; Liu Y; Tian L; Hui N; Li J; Ma Y; Li H; Zhao Q; Cao W; Liu H; Ren X
    Eur J Med Chem; 2021 Aug; 220():113451. PubMed ID: 33895500
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Diagnostic immunophenotype of acute promyelocytic leukemia before and early during therapy with all-trans retinoic acid.
    Horna P; Zhang L; Sotomayor EM; Lancet JE; Moscinski LC
    Am J Clin Pathol; 2014 Oct; 142(4):546-52. PubMed ID: 25239423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.